Steven Cohen's JANX Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 961,819 shares of Janux Therapeutics, Inc. (JANX) worth $13.27 M, representing 0.01% of the portfolio. First purchased in 2024-Q2, this short-term holding has been held for 7 quarters.
Based on 13F filings, Steven Cohen has maintained this position in JANX for several quarters, showing initial confidence in the investment. Largest addition occurred in Q2 2025, adding 1.77 M shares. Largest reduction occurred in Q4 2025, reducing 748,381 shares.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's Janux Therapeutics (JANX) Holding Value Over Time
Track share changes against reported price movement
Quarterly Janux Therapeutics (JANX) Trades by Steven Cohen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | -748,381 | Reduce 43.76% | 961,819 | $13.80 |
| Q3 2025 | -433,700 | Reduce 20.23% | 1.71 M | $24.44 |
| Q2 2025 | +1.77 M | Add 469.18% | 2.14 M | $23.10 |
| Q1 2025 | -244,721 | Reduce 39.38% | 376,662 | $27.00 |
| Q4 2024 | +225,508 | Add 56.96% | 621,383 | $53.54 |
| Q3 2024 | +259,445 | Add 190.17% | 395,875 | $45.43 |
| Q2 2024 | +136,430 | New Buy | 136,430 | $41.89 |
Steven Cohen's Janux Therapeutics Investment FAQs
Steven Cohen first purchased Janux Therapeutics, Inc. (JANX) in Q2 2024, acquiring 136,430 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held Janux Therapeutics, Inc. (JANX) for 7 quarters since Q2 2024.
Steven Cohen's largest addition to Janux Therapeutics, Inc. (JANX) was in Q2 2025, adding 2,143,900 shares worth $49.52 M.
According to the latest 13F filing for Q4 2025, Steven Cohen's firm, Point72 Asset Management, L.P., owns 961,819 shares of Janux Therapeutics, Inc. (JANX), valued at approximately $13.27 M.
As of the Q4 2025 filing, Janux Therapeutics, Inc. (JANX) represents approximately 0.01% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.
Steven Cohen's peak holding in Janux Therapeutics, Inc. (JANX) was 2,143,900 shares, as reported at the end of Q2 2025.